NSTEMI diagnosis and management US Medical PG Practice Questions and MCQs
Practice US Medical PG questions for NSTEMI diagnosis and management. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
NSTEMI diagnosis and management US Medical PG Question 1: A 67-year-old man comes to the emergency department because of retrosternal chest pressure and shortness of breath for 4 hours. The symptoms started while he was walking to work and have only minimally improved with rest. He has a history of type 2 diabetes mellitus. He has smoked one pack of cigarettes daily for 35 years. He appears uncomfortable. His pulse is 95/min. Serum studies show a normal troponin concentration. An ECG shows no abnormalities. Which of the following is the most likely underlying cause of this patient's symptoms?
- A. Atherosclerotic plaque thrombus with complete coronary artery occlusion
- B. Stable atherosclerotic plaque with 85% coronary artery occlusion
- C. Aortic valve thickening and calcification
- D. Disruption of an atherosclerotic plaque with a non-occlusive coronary artery thrombus (Correct Answer)
- E. Coronary artery occlusion due to transient increase in vascular tone
NSTEMI diagnosis and management Explanation: **Disruption of an atherosclerotic plaque with a non-occlusive coronary artery thrombus**
- This scenario describes **unstable angina (UA)**, characterized by chest pain at rest or with minimal exertion, increased frequency/intensity of angina, or new-onset severe angina.
- While troponin is normal and ECG shows no abnormalities, the persistent symptoms and minimal improvement with rest, along with risk factors like **diabetes** and **smoking**, strongly suggest an **unstable coronary lesion** that is not yet fully occlusive.
*Atherosclerotic plaque thrombus with complete coronary artery occlusion*
- **Complete coronary artery occlusion** typically leads to myocardial infarction (MI), which would manifest with **elevated troponin levels** and often **ECG changes** (e.g., ST elevation or depression).
- The patient's normal troponin and ECG rule out an acute MI at this stage.
*Stable atherosclerotic plaque with 85% coronary artery occlusion*
- **Stable angina** symptoms usually improve promptly with rest and are predictable, occurring only during significant exertion.
- The described symptoms, including minimal improvement with rest and 4 hours duration, are not typical of stable angina.
*Aortic valve thickening and calcification*
- While **aortic stenosis** can cause chest pain and shortness of breath, these symptoms are typically exertional and not usually described as "retrosternal pressure" that minimally improves with rest in this acute context without other signs of flow obstruction.
- This condition is unlikely to be the sole cause of these acute, persistent symptoms without findings on initial workup.
*Coronary artery occlusion due to transient increase in vascular tone*
- **Coronary vasospasm** (Prinzmetal angina) can cause chest pain at rest and transient ECG changes, but it's typically **recurrent** and responds well to **vasodilators**.
- This patient's symptoms, combined with risk factors for atherosclerosis and the prolonged nature of the pain, are less indicative of vasospasm as the primary underlying cause.
NSTEMI diagnosis and management US Medical PG Question 2: A medical research study is evaluating an investigational novel drug (medication 1) as compared with standard therapy (medication 2) in patients presenting to the emergency department with myocardial infarction (MI). The study enrolled a total of 3,000 subjects, 1,500 in each study arm. Follow-up was conducted at 45 days post-MI. The following are the results of the trial:
Endpoints Medication 1 Medication 2 P-Value
Primary: death from cardiac causes 134 210 0.03
Secondary: hyperkalemia 57 70 0.4
What is the relative risk of death from a cardiac cause, expressed as a percentage? (Round to the nearest whole number.)
- A. 64% (Correct Answer)
- B. 42%
- C. 72%
- D. 36%
- E. 57%
NSTEMI diagnosis and management Explanation: ***64%***
- The **relative risk (RR)** is calculated as the event rate in the exposed group divided by the event rate in the unexposed (control) group.
- For cardiac death, the event rate for Medication 1 is 134/1500 = 0.0893, and for Medication 2 is 210/1500 = 0.14. Therefore, RR = 0.0893 / 0.14 = 0.6378.
- Expressing as a percentage: 0.6378 × 100 = 63.78%, which rounds to **64%**.
- This indicates that Medication 1 has 64% of the risk of cardiac death compared to Medication 2, representing a **36% relative risk reduction**.
*42%*
- This option is incorrect as it does not reflect the accurate calculation of **relative risk** using the provided event rates.
- A calculation error or conceptual misunderstanding of the relative risk formula would lead to this value.
*72%*
- This percentage is higher than the calculated relative risk, suggesting an incorrect application of the formula or a misinterpretation of the event rates.
- It does not represent the ratio of risk between the two medication groups for cardiac death.
*36%*
- This value represents the **relative risk reduction** (100% - 64% = 36%), not the relative risk itself.
- This is a common error where students confuse relative risk with relative risk reduction.
*57%*
- While closer to the correct answer, this value is not the precise result when rounding to the nearest whole number.
- Small calculation discrepancies or rounding at intermediate steps could lead to this slightly different percentage.
NSTEMI diagnosis and management US Medical PG Question 3: A 55-year-old man comes to the physician because of a 4-month history of episodic, pressure-like chest pain. The chest pain occurs when he is walking up stairs and improves with rest. He has hypertension and type 2 diabetes mellitus. His father died from a myocardial infarction at the age of 50 years. Current medications include hydrochlorothiazide and metformin. His pulse is 85/min, respirations are 12/min, and blood pressure is 140/90 mm Hg. Cardiac examination shows normal heart sounds without any murmurs, rubs, or gallops. An ECG shows high amplitude of the S wave in lead V3. An exercise stress test is performed but stopped after 4 minutes because the patient experiences chest pain. An ECG obtained during the stress test shows sinus tachycardia and ST-segment depressions in leads V1–V4. Which of the following is the most appropriate long-term pharmacotherapy to reduce the frequency of symptoms in this patient?
- A. Metoprolol (Correct Answer)
- B. Clopidogrel
- C. Aspirin
- D. Nitroglycerin
- E. Isosorbide mononitrate
NSTEMI diagnosis and management Explanation: ***Metoprolol***
- **Beta-blockers** like metoprolol are first-line agents for **symptom relief** in stable angina by reducing myocardial oxygen demand.
- They decrease **heart rate**, **blood pressure**, and **myocardial contractility**, thereby reducing the frequency and severity of anginal episodes.
*Clopidogrel*
- **Clopidogrel** is an antiplatelet agent used primarily to prevent **thrombotic events** in patients with established cardiovascular disease or acute coronary syndromes.
- It does not directly reduce the frequency of anginal symptoms, but rather prevents progression to **myocardial infarction** or **stroke**.
*Aspirin*
- **Aspirin** is an antiplatelet medication used for **secondary prevention** of cardiovascular events by inhibiting platelet aggregation.
- While crucial for reducing cardiovascular risk, it does not directly alleviate the **frequency of anginal symptoms** themselves.
*Nitroglycerin*
- **Nitroglycerin** is a short-acting nitrate used to provide **immediate relief** of anginal pain during an acute episode.
- It is not a long-term pharmacotherapy for reducing the *frequency* of symptoms.
*Isosorbide mononitrate*
- **Isosorbide mononitrate** is a long-acting nitrate used to *prevent* angina, but it is typically a **second-line agent** after beta-blockers due to potential for **tolerance** and side effects.
- While it can reduce symptom frequency, beta-blockers are generally preferred as initial long-term therapy for symptom control.
NSTEMI diagnosis and management US Medical PG Question 4: A study is conducted to find an association between serum cholesterol and ischemic heart disease. Data is collected, and patients are classified into either the "high cholesterol" or "normal cholesterol" group and also into groups whether or not the patient experiences stable angina. Which type of data analysis is most appropriate for this study?
- A. Attributable risk
- B. Analysis of variance
- C. Chi-squared (Correct Answer)
- D. T-test
- E. Pearson correlation
NSTEMI diagnosis and management Explanation: ***Chi-squared***
- The **chi-squared test** is ideal for analyzing two **categorical variables**, such as cholesterol levels (high/normal) and the presence of stable angina (yes/no), to see if there's an association between them.
- It assesses whether the observed frequencies in each category differ significantly from the expected frequencies, under the assumption of no association.
*Attributable risk*
- **Attributable risk** quantifies the proportion of disease in an exposed group that is directly due to the exposure.
- While it might be calculated *after* establishing an association (e.g., using a chi-squared test), it's a measure of actual impact rather than a method for *finding the association* between two categorical variables.
*Analysis of variance*
- **Analysis of variance (ANOVA)** is used to compare the means of **three or more groups** for a continuous outcome variable.
- It works when you have a categorical independent variable with multiple levels and a continuous dependent variable, which is not the case here as both variables are categorical.
*T-test*
- A **t-test** is used to compare the means of **two groups** for a continuous outcome variable.
- It is not appropriate for analyzing the association between two categorical variables like cholesterol categories and angina presence.
*Pearson correlation*
- **Pearson correlation** measures the linear relationship between **two continuous variables**.
- It is unsuitable for this study as both cholesterol status and angina presence are categorical variables, not continuous.
NSTEMI diagnosis and management US Medical PG Question 5: Serum studies show a troponin T concentration of 6.73 ng/mL (N < 0.01), and fingerstick blood glucose concentration of 145 mg/dL. The cardiac catheterization team is activated. Treatment with unfractionated heparin, aspirin, ticagrelor, and sublingual nitroglycerin is begun, and the patient's pain subsides. His temperature is 37.3°C (99.1°F), pulse is 65/min, respirations are 23/min, and blood pressure is 91/60 mm Hg. Pulse oximetry on room air shows an oxygen saturation of 96%. Which of the following is the most appropriate additional pharmacotherapy?
- A. Intravenous morphine
- B. Intravenous furosemide
- C. Intravenous insulin
- D. Oral atorvastatin (Correct Answer)
- E. Intravenous nitroglycerin
NSTEMI diagnosis and management Explanation: ***Oral atorvastatin***
- All patients with **acute coronary syndrome (ACS)** should receive high-intensity statin therapy, such as **atorvastatin 80 mg daily**, as early as possible.
- Statins stabilize plaques, reduce inflammation, and improve endothelial function, which are crucial in the acute setting of a myocardial infarction.
*Intravenous morphine*
- Morphine can be used for persistent chest pain refractory to nitroglycerin, but its routine use is now questioned due to potential adverse effects like hypotension and delayed antiplatelet absorption.
- The patient's pain has already subsided with initial treatment, and his blood pressure is already low (91/60 mm Hg), making morphine less appropriate.
*Intravenous furosemide*
- Furosemide is a loop diuretic primarily used for treating **fluid overload** and **pulmonary edema**, which are not indicated by the patient's current presentation (oxygen saturation 96%, no mention of crackles or dyspnea).
- Its use in a patient with **borderline hypotension** could worsen hemodynamic stability.
*Intravenous insulin*
- While the patient has elevated fingerstick glucose (145 mg/dL), this level does not immediately require intravenous insulin unless there is evidence of **diabetic ketoacidosis** or **hyperosmolar hyperglycemic state**, or persistent severe hyperglycemia.
- More moderate hyperglycemia can often be managed with subcutaneous insulin or diet in the acute phase, and focuses remain on cardiac stabilization.
*Intravenous nitroglycerin*
- Intravenous nitroglycerin is indicated for ongoing ischemic chest pain or uncontrolled hypertension in ACS, but the patient's pain has subsided and he is **hypotensive** (91/60 mm Hg).
- Administering more nitroglycerin would likely worsen his hypotension and could compromise coronary perfusion.
NSTEMI diagnosis and management US Medical PG Question 6: A 50-year-old man presents the emergency department for intense chest pain, profuse sweating, and shortness of breath. The onset of these symptoms was 3 hours ago. The chest pain began after a heated discussion with a colleague at the community college where he is employed. Upon arrival, he is found conscious and responsive; the vital signs include a blood pressure of 130/80 mm Hg, a heart rate at 90/min, a respiratory rate at 20/min, and a body temperature of 36.4°C (97.5°F). His medical history is significant for hypertension diagnosed 7 years ago, which is well-controlled with a calcium channel blocker. The initial electrocardiogram (ECG) shows ST-segment depression in multiple consecutive leads, an elevated cardiac troponin T level, and normal kidney function. Which of the following would you expect to find in this patient?
- A. Subendocardial necrosis (Correct Answer)
- B. Transmural necrosis
- C. Incomplete occlusion of a coronary artery
- D. Coronary artery spasm
- E. Ventricular pseudoaneurysm
NSTEMI diagnosis and management Explanation: ***Subendocardial necrosis***
- This patient's presentation with **ST-segment depression** and **elevated troponin T** indicates a **Non-ST-segment Elevation Myocardial Infarction (NSTEMI)**, which typically results from subendocardial ischemia and necrosis.
- Subendocardial tissue is most vulnerable to ischemia due to its high oxygen demand and distal location from the coronary arteries, making it the first region to suffer damage when oxygen supply is compromised.
*Transmural necrosis*
- **Transmural necrosis** is characteristic of a **ST-segment Elevation Myocardial Infarction (STEMI)**, which presents with persistent **ST-segment elevation** on ECG.
- This patient's ECG shows **ST-segment depression**, ruling out transmural involvement at the time of presentation.
*Incomplete occlusion of a coronary artery*
- While an NSTEMI usually involves an **incomplete occlusion** or **critical stenosis** of a coronary artery, the question asks what would be *found* in the patient's heart tissue, not the mechanism.
- The direct tissue consequence of incomplete occlusion leading to NSTEMI is **subendocardial necrosis**, which is a more specific answer about the pathological finding.
*Coronary artery spasm*
- Although **coronary artery spasm (Prinzmetal angina)** can cause chest pain and ECG changes, it typically presents with **transient ST-segment elevation** (not depression) and often resolves spontaneously.
- The elevated troponin T indicates myocardial necrosis, which is not typically a feature of uncomplicated coronary artery spasm, and the duration of symptoms (3 hours) suggests a more sustained event than a transient spasm.
*Ventricular pseudoaneurysm*
- A **ventricular pseudoaneurysm** is a **late complication of myocardial infarction**, typically occurring weeks to months after the acute event, due to rupture of the ventricular free wall contained by pericardium.
- Given the 3-hour symptom onset, it is highly unlikely to be present in the acute phase of myocardial infarction.
NSTEMI diagnosis and management US Medical PG Question 7: A 28-year-old male presents to his primary care physician with complaints of intermittent abdominal pain and alternating bouts of constipation and diarrhea. His medical chart is not significant for any past medical problems or prior surgeries. He is not prescribed any current medications. Which of the following questions would be the most useful next question in eliciting further history from this patient?
- A. "Does the diarrhea typically precede the constipation, or vice-versa?"
- B. "Is the diarrhea foul-smelling?"
- C. "Please rate your abdominal pain on a scale of 1-10, with 10 being the worst pain of your life"
- D. "Are the symptoms worse in the morning or at night?"
- E. "Can you tell me more about the symptoms you have been experiencing?" (Correct Answer)
NSTEMI diagnosis and management Explanation: ***Can you tell me more about the symptoms you have been experiencing?***
- This **open-ended question** encourages the patient to provide a **comprehensive narrative** of their symptoms, including details about onset, frequency, duration, alleviating/aggravating factors, and associated symptoms, which is crucial for diagnosis.
- In a patient presenting with vague, intermittent symptoms like alternating constipation and diarrhea, allowing them to elaborate freely can reveal important clues that might not be captured by more targeted questions.
*Does the diarrhea typically precede the constipation, or vice-versa?*
- While knowing the sequence of symptoms can be helpful in understanding the **pattern of bowel dysfunction**, it is a very specific question that might overlook other important aspects of the patient's experience.
- It prematurely narrows the focus without first obtaining a broad understanding of the patient's overall symptomatic picture.
*Is the diarrhea foul-smelling?*
- Foul-smelling diarrhea can indicate **malabsorption** or **bacterial overgrowth**, which are important to consider in some gastrointestinal conditions.
- However, this is a **specific symptom inquiry** that should follow a more general exploration of the patient's symptoms, as it may not be relevant if other crucial details are missed.
*Please rate your abdominal pain on a scale of 1-10, with 10 being the worst pain of your life*
- Quantifying pain intensity is useful for assessing the **severity of discomfort** and monitoring changes over time.
- However, for a patient with intermittent rather than acute, severe pain, understanding the **character, location, and triggers** of the pain is often more diagnostically valuable than just a numerical rating initially.
*Are the symptoms worse in the morning or at night?*
- Diurnal variation can be relevant in certain conditions, such as inflammatory bowel diseases where nocturnal symptoms might be more concerning, or functional disorders whose symptoms might be stress-related.
- This is another **specific question** that should come after gathering a more complete initial picture of the patient's symptoms to ensure no key information is overlooked.
NSTEMI diagnosis and management US Medical PG Question 8: A 62-year-old man with a past medical history of previous myocardial infarction, angina, hypertension, hyperlipidemia, diabetes mellitus, peripheral vascular disease, and below knee amputation has developed new chest pain. His medication includes insulin, hydrochlorothiazide, lisinopril, metoprolol, daily aspirin, atorvastatin, and nitroglycerin as needed. His vitals include: blood pressure 135/87 mm Hg, pulse 52/min, and respirations 17/min. Coronary arteriography shows a reduced ejection fraction, a 65% stenosis of the left anterior descending artery, and a 75% stenosis of the left circumflex artery. Which of the following is the recommended treatment for the patient?
- A. Increased beta blocker dosage
- B. Coronary artery bypass grafting (CABG) (Correct Answer)
- C. Angioplasty with stent placement
- D. Extended release nitrate therapy
- E. Heparin
NSTEMI diagnosis and management Explanation: ***Coronary artery bypass grafting (CABG)***
- This patient has complex **multivessel coronary artery disease** (LAD and circumflex stenosis) with a **reduced ejection fraction** and a history of multiple comorbidities, making CABG the preferred revascularization strategy for improved outcomes.
- CABG offers a more complete revascularization in patients with significant disease burden and reduced left ventricular function, leading to better long-term survival and symptom relief compared to PCI in this population.
*Increased beta blocker dosage*
- The patient's current heart rate is 52/min, which is already at the lower end of the target range for beta-blocker therapy in cardiac patients, and further increasing the dose could lead to **bradycardia** and worsening symptoms.
- While beta-blockers are crucial for managing angina and improving outcomes post-MI, increasing the dose wouldn't address the underlying anatomical severe multi-vessel coronary artery disease.
*Angioplasty with stent placement*
- Although PCI (angioplasty with stent placement) can be used for coronary stenosis, in patients with **multivessel disease**, **reduced ejection fraction**, and **diabetes mellitus**, CABG generally offers superior long-term results and survival benefits.
- The complexity of the lesions (65% LAD, 75% circumflex) in a patient with significant comorbidities and extensive atherosclerotic disease makes PCI a less optimal choice here.
*Extended release nitrate therapy*
- Nitrates primarily provide **symptomatic relief** by causing vasodilation, but they do not address the severe underlying coronary stenoses or improve long-term outcomes in patients with complex, multivessel disease.
- The patient is already on PRN nitroglycerin, and while extended-release nitrates could help with angina, they are not a definitive treatment for significant arterial blockages requiring revascularization.
*Heparin*
- Heparin is an **anticoagulant** that may be used as part of initial management of acute coronary syndromes, but it provides only temporary stabilization and does not address the **definitive need for revascularization**.
- While anticoagulation plays a role in acute management, this patient requires **definitive anatomical correction** of his multivessel disease with significant stenoses, which only surgical or percutaneous revascularization can provide, with CABG being superior given his clinical profile.
NSTEMI diagnosis and management US Medical PG Question 9: Two days after undergoing an uncomplicated total thyroidectomy, a 63-year-old woman has acute, progressive chest pain. The pain is sharp and burning. She feels nauseated and short of breath. The patient has a history of hypertension, type 1 diabetes mellitus, medullary thyroid cancer, multiple endocrine neoplasia type 2A, anxiety, coronary artery disease, and gastroesophageal reflux disease. She smoked half a pack of cigarettes daily for 24 years but quit 18 years ago. Current medications include lisinopril, insulin glargine, insulin aspart, sertraline, aspirin, ranitidine, and levothyroxine. She appears anxious and diaphoretic. Her temperature is 37.4°C (99.3°F), pulse is 64/min, respirations are 17/min, and blood pressure is 148/77 mm Hg. The lungs are clear to auscultation. Examination shows a 3-cm linear incision over the anterior neck with 1 mm of surrounding erythema and mild serous discharge. The chest wall and abdomen are nontender. There is 5/5 strength in all extremities and decreased sensation to soft touch on the feet bilaterally. The remainder of the examination shows no abnormalities. Which of the following is the most appropriate next step in management?
- A. Obtain an ECG and troponin T levels (Correct Answer)
- B. Administer IV pantoprazole and schedule endoscopy
- C. Discontinue levothyroxine and obtain fT4 levels
- D. Administer IV levofloxacin and obtain chest radiograph
- E. Obtain urine and plasma metanephrine levels
NSTEMI diagnosis and management Explanation: **Obtain an ECG and troponin T levels**
- The patient presents with acute, progressive **chest pain that is sharp and burning**, along with nausea and shortness of breath, which are classic symptoms of an acute coronary syndrome, especially given her history of **coronary artery disease**, hypertension, diabetes, and prior smoking.
- An **ECG** and **troponin T levels** are crucial first steps to evaluate for myocardial ischemia or infarction in this high-risk patient.
*Administer IV pantoprazole and schedule endoscopy*
- While the patient has a history of gastroesophageal reflux disease (GERD) and her pain is described as "burning," the **acuteness, progression, and associated symptoms** (nausea, shortness of breath) in a patient with significant cardiac risk factors make a GI cause less likely as the primary concern.
- Empiric treatment for GERD without first ruling out a life-threatening cardiac event would be inappropriate and potentially dangerous.
*Discontinue levothyroxine and obtain fT4 levels*
- The patient is taking levothyroxine after a thyroidectomy for medullary thyroid cancer, but there is no immediate indication of thyroid hormone imbalance (e.g., hyperthyroidism causing chest pain) that would warrant discontinuing her medication or rushing fT4 levels as the first step in an acute chest pain presentation.
- Her pulse of 64/min is not suggestive of hyperthyroidism, which typically causes tachycardia.
*Administer IV levofloxacin and obtain chest radiograph*
- While shortness of breath can be a symptom of pneumonia, the **sharp, burning nature of the chest pain**, coupled with the absence of fever (temperature 37.4°C is mild), cough, or abnormal lung sounds (lungs clear to auscultation), makes an acute infection like pneumonia less probable as the primary diagnosis.
- Antibiotics and a chest radiograph would be considered after ruling out more immediate life-threatening conditions like acute coronary syndrome.
*Obtain urine and plasma metanephrine levels*
- The patient has a history of multiple endocrine neoplasia type 2A (MEN2A), which includes medullary thyroid cancer and can be associated with pheochromocytoma (adrenal tumor secreting catecholamines). However, her blood pressure (148/77 mm Hg) is not acutely elevated to crisis levels, and her symptoms are more consistent with cardiac ischemia than a pheochromocytoma crisis.
- While metanephrine levels would be important for long-term follow-up of MEN2A, they are not the immediate next step for acute chest pain in a patient with known coronary artery disease.
NSTEMI diagnosis and management US Medical PG Question 10: A 72-year-old female presents to the emergency department following a syncopal episode while walking down several flights of stairs. The patient has not seen a doctor in several years and does not take any medications. Your work-up demonstrates that she has symptoms of angina and congestive heart failure. Temperature is 36.8 degrees Celsius, blood pressure is 160/80 mmHg, heart rate is 81/min, and respiratory rate is 20/min. Physical examination is notable for a 3/6 crescendo-decrescendo systolic murmur present at the right upper sternal border with radiation to the carotid arteries. Random blood glucose is 205 mg/dL. Which of the following portends the worst prognosis in this patient?
- A. Hypertension
- B. Angina
- C. Diabetes
- D. Syncope
- E. Congestive heart failure (CHF) (Correct Answer)
NSTEMI diagnosis and management Explanation: ***Congestive heart failure (CHF)***
- Once **congestive heart failure** symptoms develop in severe aortic stenosis, the prognosis is very poor, with an average survival of 1.5-2 years if untreated.
- This indicates significant myocardial dysfunction and increased risk of sudden cardiac death.
*Syncope*
- **Syncope** in aortic stenosis, while serious and indicating reduced cerebral perfusion, has a slightly better prognosis than CHF, with an average survival of 2-3 years untreated.
- It often reflects a critical reduction in cardiac output, but the heart muscle itself may still have some compensatory capacity.
*Angina*
- **Angina** is a common symptom of aortic stenosis, reflecting increased myocardial oxygen demand or reduced coronary perfusion.
- Untreated, patients with angina in aortic stenosis have an average survival of 3-5 years, which is better than syncope or CHF.
*Hypertension*
- While **hypertension** is a risk factor for aortic stenosis and can exacerbate symptoms, it is not a direct symptom of severe aortic stenosis itself but rather a co-morbidity.
- Its presence doesn't inherently portend a worse prognosis for aortic stenosis than the severe symptomatic manifestations like syncope or CHF.
*Diabetes*
- **Diabetes** is a systemic disease that can accelerate atherosclerosis and increase cardiovascular risk, but it is a chronic condition rather than an acute symptom of severe aortic stenosis.
- While it complicates management and overall prognosis, its impact is not as immediate or as severe as the development of CHF directly attributable to the aortic stenosis itself.
More NSTEMI diagnosis and management US Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
